Only one experimental shot, made by Merck, has been approved for use amid the current outbreak
The canine clinical trial will vaccinate 800 healthy pets
For 200 years, the USP, founded as United States Pharmacopeia, has been working behind the scenes to help ensure that medicines are what they claim. What’s next for one of the most important standards-setting organizations that you’ve never heard of?
The final decision about which potential therapies to allow rests with the DRC government
Pediatric cardiologist Ismée Williams discusses her young adult novel, Water in May, about a teenage girl whose newborn has a life-threatening heart condition.
The agency’s first target will be hemophilia
Cancer treatment using the notorious drug may hold promise for other diseases like Alzheimer’s
The state is the first to approve such legislation, but importation would still require federal sign-off
Clinical trial patients had two fewer headaches a month compared with those who received a placebo
Public health workers are preparing to roll out inoculations even as the disease has spread to an urban location
How emerging diseases in a changing world jeopardize public health, and what can be done
Orangutans were observed to use plant extracts to treat their own pain.
The inoculation, called V920, was developed by Merck
One experimental shot is slated for human testing
The White House proposal would not allow Medicare to negotiate prices or expand medication imports
The same preventive shot may be less effective in poor neighborhoods than in rich ones
A program to stop deadly diseases from spreading to the U.S. by helping foreign countries contain them now faces steep cuts
An experimental approach may arm immune cells against many strains, eliminating annual guesswork
Resurgent outbreaks of infectious diseases are sickening thousands, and the causes are societal